COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 794: Articles 7931-7940  | Next

SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial
Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., te Boekhorst, P. A., Swaneveld, F., Novotny, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J., Heijmans, J.
10.1101/2022.04.04.22273314 — Posted: 2022-04-05
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients
Aggarwal, N., Beatty, L., Bennett, T. D., Carlson, N., Davis, C., Kwan, B., Mayer, D., Ong, T., Russell, S., Steele, J., Wogu, A., Wynia, M., Zane, R., Ginde, A. A.
10.1101/2022.04.03.22273360 — Posted: 2022-04-05
Surface detection of SARS-CoV-2 by lateral flow LAMP
Acker, I. D., Ware, M. J., Bracht, J. R.
10.1101/2022.04.04.487067 — Posted: 2022-04-04
The new normal? Dynamics and scale of the SARS-CoV-2 variant Omicron epidemic in England
Eales, O., de Oliveira Martins, L., Page, A., Wang, H., Bodinier, B., Tang, D., Haw, D., Jonnerby, J., Atchison, C., Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., Riley, S., Elliott, P., Donnelly, C. A., Chadeau-Hyam, M.
10.1101/2022.03.29.22273042 — Posted: 2022-04-04
Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice
Natekar, J. P., Pathak, H., Stone, S., Kumari, P., Sharma, S., Arora, K., Rothan, H. A., Kumar, M.
10.1101/2022.04.04.486975 — Posted: 2022-04-04
Glasses and risk of COVID-19 transmission - analysis of the Virus Watch Community Cohort study.
Navaratnam, A. M. D., O'Callaghan, C., Beale, S., Nguyen, V., Aryee, A., Braithwaite, I., Byrne, T. E., Fong, W. L. E., Fragaszy, E., Geismar, C., Hoskins, S., Kovar, J., Patel, P., Shrotri, M., Weber, S., Yavlinsky, A., Aldridge, R. W., Hayward, A. C.
10.1101/2022.03.29.22272997 — Posted: 2022-04-04
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is mediated by a stereotyped clonotypic antibody
Wang, J. J., Armour, B., Chataway, T., Troelnikov, A., Colella, A., Yacoub, O., Hockley, S., Tan, C. W., Gordon, T. P.
10.1101/2022.03.28.22272975 — Posted: 2022-04-04
Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections
Kratochvil, M. J., Kaber, G., Demirdjian, S., Cai, P. C., Burgener, E. B., Nagy, N., Barlow, G. L., Popescu, M., Nicolls, M. R., Ozawa, M. G., Regula, D. P., Pacheco-Navarro, A. E., Yang, S., de Jesus Perez, V., Karmouty-Quintana, H., Peters, A. M., Zhao, B., Buja, M. L., Johnson, P. Y., Vernon, R. B., Wight, T. N., Stanford COVID-19 Biobank Study Group, , Rogers, A. J., Spakowitz, A. J., Milla, C. E., Heilshorn, S. C., Bollyky, P. L.
10.1101/2022.03.28.22272848 — Posted: 2022-04-04
The trustworthiness and impact of trial preprints for COVID-19 decision-making: A methodological study
Zeraatkar, D., Pitre, T., Leung, G., Cusano, E., Argawal, A., Khalid, F., Escamilla, Z., Cooper, M., Ghadimi, M., Wang, Y., Verdugo, F., Rada, G., Kum, E., Qasim, A., Bartoszko, J. J., Siemieniuk, R., Patel, C. J., Guyatt, G., Brignardello-Petersen, R.
10.1101/2022.04.04.22273372 — Posted: 2022-04-04
Significant impacts of the COVID-19 pandemic on race/ethnic differences in USA mortality
Aburto, J. M., Tilstra, A. M., Floridi, G., Dowd, J. B.
10.1101/2022.04.04.22273385 — Posted: 2022-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).